ACRF Drug Discovery Program

Program Head:  Professor Philip Hogg (biography)

RESEARCH AREAS
Development of a new class of cancer drugs
 
This program was established at the Institute in 2003. It is devoted to the design, synthesis and testing of novel anticancer compounds.